IVX Health, a Brentwood, Tenn.-based provider of outpatient infusion centers, closed a $100m Series F minority investment from Great Hill Partners.
Great Hill joins IVX Health’s existing investors including Linden Structured Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital. In connection with the investment, Mark Taber, a Managing Director at Great Hill Partners, will join IVX Health’s Board of Directors.
Led by Doug Ghertner, CEO, IVX Health is a national provider of infusion and injection therapy for those with complex chronic conditions such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis and other conditions. It offers an alternative to hospital-based infusion and injection services via local centers that offer guaranteed private suites, large flat screen TVs, high-speed Wi-Fi, leather recliners with chairs for guests, and flexible, on-demand scheduling, including evening and weekend appointments.
Operating over 50 infusion centers across 16 markets, the company will use the funding to accelerate entry into new markets in 2022 and beyond as it seeks to fulfill its vision of becoming the nation’s preferred destination of pharmaceutical care for patients with complex chronic conditions such as multiple sclerosis, Crohn’s disease, and rheumatoid arthritis, among others.